At Laguna Bio, our work is centered on unlocking the potential of unconventional immune cells to address areas of significant unmet medical need. By combining deep biological insights with advanced engineering approaches, we are building a platform designed to expand the possibilities of cell-based therapeutics.

Why Unconventional Immune Cells Matter

While much of the field has focused on traditional T-cell approaches, researchers are increasingly exploring immune cell populations that possess unique biological characteristics. These cells may offer advantages in persistence, tissue accessibility, and the ability to recognize disease through mechanisms that differ from conventional adaptive immune responses.

Understanding these distinct capabilities opens the door to therapeutic strategies that could complement—or in some cases improve upon—existing approaches.

Building with Translation in Mind

Scientific discovery is only one part of successful therapeutic development. Equally important is designing programs that can move efficiently from the laboratory toward the clinic.

Our research teams continually evaluate:

• Disease biology and patient need

• Manufacturability and scalability

• Biomarker strategies

• Preclinical performance

• Future clinical development pathways

This translational mindset helps guide decision-making at every stage of development.

Collaboration Drives Progress

Breakthroughs rarely happen in isolation. Academic researchers, clinicians, technology innovators, and biotechnology companies each contribute unique perspectives that accelerate scientific progress.

We believe collaboration strengthens every aspect of drug development—from understanding disease mechanisms to identifying new therapeutic opportunities and improving patient outcomes.

Looking Ahead

The field of immune cell engineering continues to evolve rapidly, and we are excited by the growing body of research that is reshaping how we think about immune-based therapies.

As our programs advance, we look forward to sharing updates on our scientific progress, platform innovations, and the partnerships helping move the field forward.

Together, we believe the next generation of immune cell therapies has the potential to transform how serious diseases are treated.